Research

Seed funding
#Drug discovery #Research

Acquisition to create breakthrough approach for clinical trials 

THREAD has acquired Modus Outcomes to combine high-technology and high-science in one platform designed to achieve higher-quality outcomes for research sponsors.   As clinical trials have grown more complex, so has effectively designing and implementing endpoints, which are now required in most research studies. With this acquisition, THREAD… Read More

#News #Trending News

#Biology #Covid-19 #Research

SARS-CoV-2 virus does not infect blood vessels, study shows 

University of Queensland (UQ) researchers have found that the SARS-CoV-2 virus does not infect blood vessels, despite the high risk of blood clots in Covid-19 patients. They found that the cardiovascular complications of Covid-19 are triggered by inflammation caused by infected airway cells.  Dr Emma Gordon and… Read More

#News #Trending News

#Immunology / Virology & Vaccines #Research

Vaccine against oral hookworm could save millions 

Researchers at The University of Queensland (UQ) have made a significant breakthrough in the development of a vaccine to prevent hookworm infection – a parasite which causes serious disease in tens of millions of people around the world. Trials of the vaccine candidate in mice indicate that it… Read More

#News

#Drug development #Drug discovery #Drug targets #Protein chemistry / Proteomics #Research

Trivalent PROTACs more potent in targeted protein degradation 

Researchers from the University of Dundee and Promega Corporation have shown how a “three-headed hydra” significantly improves efficacy in targeted protein degradation. The research is published in Nature Chemical Biology.  Targeted protein degradation is an area of chemical biology that is said to be revolutionising drug discovery. It involves… Read More

#News

#Collaboration #Drug discovery #Funding #Research

This week in drug discovery (18-22 October) 

News round-up by DDW’s Megan Thomas for 18-22 October  DDW’s Megan Thomas has selected five stories which highlight the opportunities in the drug discovery sector.   1. Researchers receive $4 million for exceptional junior scientists  Two Mount Sinai cancer researchers will receive $4… Read More

#News

#AI / data analytics / healthtech / informatics #Assay #Drug discovery #Electronic Lab Notebooks (ELN) #Research #Screening

Digitalisation of VIB’s biomedical research with CDD Vault 

This paid-for advertorial by CDD Vault appeared in the DDW / ELRIG UK Drug Discovery 2021 supplement in DDW Volume 22, Issue 4 – Fall 2021   For any research-based organisation in the life sciences arena, experimental data is the key to deriving biological and biochemical insight and understanding, and ultimately driving… Read More

#Exclusive Content

#Drug discovery #R&D #Research

Brochure: Cubis laboratory balances in vaccine R&D 

A new brochure by Sartorius is now available to download.   Vaccination is the most effective method of preventing infectious diseases, and is considered one of the greatest achievements in medicine. Until today, various vaccines against several crucial diseases (including influenza, chicken pox, or HPV) have been developed that save… Read More

#News

#Automation / robotics #Biobanking #Biorepository #Clinical research #Life sciences #Research

Brooks Automation and Cleveland Clinic biobank collaboration 

Brooks Automation and Cleveland Clinic have opened a 22,000-square-foot biospecimen sample management and repository facility on Cleveland Clinic’s main campus.   The biorepository is managed by Azenta Life Sciences, Brooks’ recently re-branded life sciences division, and includes ultra-cold and cryogenic storage for researchers at Cleveland Clinic and other institutions. The… Read More

#News

#Alzheimer's #Biotechnology #Covid-19 #Research

How has the pandemic impacted Alzheimer’s research? 

Sara Imarisio, Head of Strategic Initiatives at Alzheimer’s Research UK, reveals what dementia research could deliver and how Alzheimer’s research can help us re-imagine a future in which lives are saved.  Alzheimer’s and other forms of dementia have been impacted by Covid-19. With many labs forced to close during lockdown, and social… Read More

#Editor's Choice #Exclusive Content #News #Opinion

#Imaging #Research #Translational

Are imaging innovations the secret weapon against cancer?

Prachi Bogetto leads the Translational Research business at Leica Microsystems, and discusses the importance of imaging innovations when it comes to the fight against cancer. Drug discovery is increasingly informed by scientific insight derived using artificial intelligence (AI). In microscopy, in particular, computational solutions powered by AI and machine learning… Read More

#Editor's Choice #Exclusive Content #News

#Collaboration #Drug development #Drug discovery #Research

This week in drug discovery (11-15 October) 

News round-up by DDW’s Megan Thomas for 11-15 October   For this week’s drug discovery round up, DDW’s Megan Thomas has selected five stories that showcase how organisations and collaboration within the drug discovery industry can provide researchers and drug developers with the tools they need to move forward with… Read More

#News

#Covid-19 #Immunology / Virology & Vaccines #Research

Why some people have stronger natural defences against SARS-COV-2 

A team of scientists at the MRC University of Glasgow Centre for Virus Research has revealed key research into the natural human antiviral defences against SARS-CoV-2, the virus that causes Covid-19.   In the study, the scientists reveal that some people have a version of a gene,… Read More

#News

#Cancer research #Oncology #Research #Small molecules

Novel therapy could be effective against paediatric leukaemia

Mount Sinai researchers have developed a therapy that shows promise against a fatal paediatric leukaemia. The small-molecule therapy was highly effective in fighting a type of acute myeloid leukaemia in both in vitro and in vivo experiments, according to research published in Science Translational Medicine in September 2021. The therapy, named MS67, causes… Read More

#News

#Antibodies #Covid-19 #Drug discovery #Drug therapy #Infographic #Monoclonal antibodies #Research

Study illuminates surfaces of spike most resistant to antibody escape 

Scientists at La Jolla Institute for Immunology (LJI) have published a detailed map of where human antibodies bind to SARS-CoV-2, which was generated by a global collaboration comparing nearly all leading clinical candidates. The new research, published in Science, will guide the development of more effective Covid-19 antibody… Read More

#Covid-19 #News

#Cancer research #Research #Tumour biology

Proteogenomics study suggests treatment for pancreatic cancer 

A large, international collaboration led by researchers from the Johns Hopkins Kimmel Cancer Center has identified promising new targets for pancreatic cancer treatment and early diagnosis after examining various aspects of these tumours’ genes and proteins.  “Right now, patients with pancreatic cancer have very few options, and the wealth… Read More

#Cancer Research #News